top of page
Relentless Pursuit to Cure
Antibodies targeted to CD147
Ibex announces publication of Antibodies targeted to CD147 (patent pending)
The disclosure provides novel antibody sequences that bind to CD147 and inhibit viral or parasite invasion, reduce inflammation, and reduce cancer cell viability. The present disclosure also provides methods of using these antibodies to treat viral infection and cancer.
Click here to view patent: Antibodies targeted to CD147
bottom of page